Journal of Modern OncologyJournal of Modern Oncology1815-14341815-1442LLC Obyedinennaya Redaktsiya26627Research ArticleSovremennye vozmozhnosti korrektsii khronicheskoy anemii u onkologicheskikh bol'nykhZhukovN V-KurmukovI A-1506200682545709042020Copyright © 2006, Consilium Medicum2006онкологические заболеванияанемиягемоглобинэритропоэтин βрекормон[Ludwig H, Van Belle S, Barrett-Lee P. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004 Oct; 40 (15): 2293-306.][Mercadante S, Gebbia V, Marrazzo A et al. Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000; 26: 303-11.][Groopman J.L, Itri L. Chemotherapy induced anemia in adults: Incidence and treatment. J Natl Cancer Inst 1999; 91: 1616-34.][Carnot P, De Flandre C. Sur l’activite hemopoietique de erum au cours de la regeneration du sang. C R Acad Sci (Paris) 1906; 143: 384-6.][Miyake T, Kung C.K.H, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252: 5558-64.][Jacobs K, Shoemaker C, Rudersdorf R et al. Isolation and characterization of genomic cDNA clones of human erythropoietin. Nature 1985; 313: 806-10.][Lin F.K, Suggs S, Lin C.H et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 92: 7850-84.][Eschbach J.W, Egrie J.C, Downing M.R et al. Correction of the anemia of end - stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73-8.][Ludwig H, Fritz E, Kotzmann H et al. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693-9.][Miller C.B, Jones R.J, Piantadosi S et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-92.][Koury M.J, Bondurant M.C. Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin. Transfusion 1990; 30: 673-4.][Bokemeyer C, Aapro M.S, Courdi A et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2004.][Rizzo J.D, Lichtin A.E, Woolf S.H et al. Use of epoetin in patients with cancer: evidence - based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002; 20: 4083-107.][National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology - v.2.2005 Cancer and Treatment Related Anemia.][Crawford J, Cella D, Cleeland C.S et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002; 95: 888-95.][Bohlius J.F, Langensiepen S, Schwarzer G et al. Does erythropoietin improve overall survival in the treatment of patients with malignant diseases? Results of a comprehensive meta - analysis. Blood 2003; 102: 203a [abstr 709].][National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology - v.2.2005 Cancer and Treatment Related Anemia.][Bokemeyer C, Aapro M.S, Courdi A et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2004.][Szucs T.D, Boogaerts M.A, Coiffier B et al. Cost - effectiveness of epoetin b in the management of cancer - related anaemia. Proceedings of the 6th Annual Meeting of the European Haematology Association, 21-24 June 2001, Frankfurt, Germany. Hematol J 2001; 2 (Suppl. 1): 67 (Abstr 192).]